The MFDS has decided to disclose the results of the drug GMP survey on its website in the future. The MFDS has prepared a plan to disclose information on the results of the drug GMP survey based on the discussions discussed through the Public-Private Consultative Body on the Results of the GMP Survey. As a PIC/S member country, the results of the survey will be disclosed at the level of the U.S. and Europe, but in consideration of the need to prepare legal grounds, it will gradually disclose detailed information after the revision of the Pharmaceutical Affairs Act in the first stage.

Subject to the disclosure are pharmaceuticals and herbal medicines under the jurisdiction of the Drug Safety Bureau, and